口蹄疫疫苗研究进展

›› 2013, Vol. 40 ›› Issue (7): 171-174.

口蹄疫疫苗研究进展

张元沛¹, 李彦芹², 王玲玲¹, 高运东², 仲跻峰²

1. 山东奥克斯生物技术有限公司, 山东济南 250100;
2. 山东省农业科学院奶牛研究中心, 山东济南 250100

修回日期:2013-04-26 出版日期:2013-07-20 发布日期:2013-07-24
通讯作者: 仲跻峰 E-mail:sdox2@163.com
作者简介:张元沛(1985-),男,山东人,助理畜牧师,研究方向:遗传育种。
基金资助:
国家奶牛产业技术体系建设专项经费(CARS-37)。

Research Progress on Foot-and-mouth Disease Vaccine

ZHANG Yuan-pei¹, LI Yan-qin², WANG Ling-ling¹, GAO Yun-dong², ZHONG Ji-feng²

1. Shandong OX Biotech Co., Ltd., Jinan 250100, China;
2. Cow Research Center, Shandong Agricultural Academy, Jinan 250100, China

Revised:2013-04-26 Online:2013-07-20 Published:2013-07-24

摘要/Abstract

摘要： 口蹄疫是一种高度接触性和经济毁灭性传染病,疫苗接种是防控该病的主要措施。随着科学技术的进步,口蹄疫疫苗的研制在不断改进和发展,作者对口蹄疫疫苗的研究进展进行了综述。

关键词: 口蹄疫; 疫苗; 进展

Abstract: Foot-and-mouth disease (FMD) is a highly contagious and economically devastating viral disease. Vaccination is the main measures to prevent and control the disease. With the development of scientific technology, the research of foot-and-mouth disease vaccines are improving and developing, this paper reviewed the development of foot-and-mouth disease vaccines.

Key words: foot-and-mouth disease; vaccine; progress

中图分类号:

S852.4

张元沛, 李彦芹, 王玲玲, 高运东, 仲跻峰. 口蹄疫疫苗研究进展[J]. , 2013, 40(7): 171-174.

ZHANG Yuan-pei, LI Yan-qin, WANG Ling-ling, GAO Yun-dong, ZHONG Ji-feng. Research Progress on Foot-and-mouth Disease Vaccine[J]. China Animal Husbandry & Veterinary Medicine, 2013, 40(7): 171-174.

参考文献

1 王明俊. 兽医生物制品学[M]. 北京: 中国农业出版社,1997.
2 王永录, 张永光, 方玉珍, 等. 牛O-A型口蹄疫双价灭活苗研究: 效力试验和最小免疫剂量试验[J]. 中国兽医科技,1999, 29 (9): 3~4.
3 张永光, 王永录, 方玉珍, 等. 牛O-A型口蹄疫双价灭活苗研究: 疫苗制备及其安全效力试验[J]. 中国兽医科技, 1996, 26 (5): 3~5.
4 杨永钦,李乐.口蹄疫疫苗Asia 1型灭活苗的研究[J].中国畜禽传染病, 1995, 82(3):29~30.
5 殷震, 刘景华. 动物病毒学[M]. 第2版. 北京: 科学出版社,1997.
6 Alejo D M,Moraes M P,Liao X, et al. An adenovirus vectored mucosal adjuvant augments protection of mice immunized intranasally with an adenovirus-vectored foot-and-mouth disease virus subunit vaccine[J].Vaccine, 2013, 31 (18): 2302~2309.
7 Bahnemann H G. Binary ethylenimine as an inactivant for foot-and-mouth disease virus and its application for vaccine production[J]. Arch Virol, 1975, 47(1):47~56.
8 Brown F, Newman J F. In vitro measurement of the potency of inactivated foot-and-mouth disease virus vaccines[J]. J Hyg, 1963, 61:345~351.
9 Carrillo C, Wigdorovitz A, TronoK, et al. Induction of a virus specific antibody response to foot-and-mouth disease virus using the structural protein VP1 expressed in transgenic potatoes plants[J]. Virol Immunol, 2001, 14: 49~57.
10 Chan E W, Wong H T, Cheng S C, et al. An immunoglobulin G based chimeric protein induced foot-and-mouth disease specific immune response in swine[J]. Vaccine, 2000, 19(4~5): 538~546.
11 Chinsangaram J, Beard C, Mason P W, et al. Antibody response in mice inoculated with DNA expressing foot-and-mouth disease virus capsid proteins[J]. J Virol,1998, 72(5):4454~4457.
12 Du Y, Jiang P, Li Y, et al. Immune responses of two recombinant adenoviruses expressing VP1 antigens of FMDV fused with porcine granulocyte macrophage colony-stimulating factor[J]. Vaccine, 2007, 25(49): 8209~8219.
13 Frenkel H S. The cultivation of the virus on a practical scale in explantation bovine tongue epithelium[J]. Am J Vet Res,1951, 17(3):224~228.
14 Fowler V, Robinson L, Bankowski B, et al. A DNA vaccination regime including protein boost and electroporation protects cattle against foot-and-mouth disease[J]. Antiviral Res,2012, 94(1): 25~34.
15 Grubman M J, Moraes M P, Schutta C, et al. Adenovirus serotype 5-vectored foot-and-mouth disease subunit vaccines: the first decade[J]. Future Virol, 2010, 5(1): 51~64.
16 Lombard M, Pastoret P P, Moulin A M. A brief history of vaccines and vaccination[J]. Rev Sci Tech, 2007, 26(1): 29~48.
17 Li Y, Stirling C M, Denyer M S, et al. Dramatic improvement in FMD DNA vaccine efficacy and cross-serotype antibody induction in pigs following a protein boost[J]. Vaccine, 2008, 26(21):2647~2656.
18 Li P, Zhang Y G, Wang Y L, et al. Foliar extracts from transgenic tomato plants expressing the structural poly protein, P1-2A, and protease, 3C, from foot-and-mouth disease virus elicit a protective response in guinea pigs[J]. Vet Immunol Immunopathol, 2008, 121(1): 83~90.
19 Moraes M P, Mayr G A, Mason P W, et al. Early protection against homologous challenge after a single dose of replication-defective human adenovirus type 5 expressing capsid proteins of foot-and-mouth disease virus (FMDV) strain A24[J]. Vaccine,2002, 20(11~12): 1631~1639.
20 Pacheco J M, Brum M C, Moraes M P, et al. Rapid protection of cattle from direct challenge with foot-and-mouth disease virus (FMDV) by a single inoculation with an adenovirus-vectored FMDV subunit vaccine[J]. Virology, 2005, 337(2): 205~209.
21 Pacheco J M. Rapid protection of cattle from direct challenge with foot-and-mouth disease virus (FMDV) by a single inoculation with an adenovirus-vectored FMDV subunit vaccine[J]. Virology, 2005, 337(2): 205~209.
22 Rao J P,Agrawal P,Mohammad R,et al. Expression of VP1 protein of serotype A and O of foot-and-mouth disease virus in transgenic sunnhemp plants and its immunogenicity for guinea pigs[J]. Acta Virol,2012, 56(2):91~99.
23 Sanz-Parra A,Jimenez-Clavero M A, Garcia-Briones M M, et al. Recombinant viruses expressing the foot-and-mouth disease virus capsid precursor polypeptide P1 induce cellular but not homoral antiviral immunity and partial protection in pigs[J]. Virology, 1999, 259(1): 129~134.
24 Taboga O, Tami C, Carrillo E, et al. A large-scale evaluation of peptide vaccines against foot-and-mouth disease: Lack of solid protection in cattle and isolation of escape mutants[J]. J Virol, 1997, 71(4): 2606~2614.
25 Ward G, Rieder E, Mason P W. Plasmid DNA encoding replicating foot-and-mouth disease virus genomes induces antiviral immune responses in swine[J]. J Virol, 1997, 71(10): 7442~7447.
26 Yang N S, Wang J H, Lin K F, et al. Comparative studies of the capsid precursor polypeptide P1 and the capsid protein VP1 cDNA vectors for DNA vaccination against foot-and-mouth disease virus[J]. J Gene Med, 2005, 7(6): 708~717.
27 Yu X, Xiao S, Jiang Y, et al. A DNA vaccine encoding the FMDV capsid precursor polypeptide P1 and the enhancing effect of bovine herpesvirus 1 VP22 protein as molecular adjuvant[J].Acta Virol, 2012, 56(2):111~117.
28 Zhou G, Wang H, Wang F, et al. Recombinant adenovirus expressing type Asia 1 foot-and-mouth disease virus capsid proteins induces protective immunity against homologous virus challenge in mice[J]. Res Vet Sci, 2013, 94(3):796~802.

[1]	焦显芹, 马晓, 田润博, 刘颖, 马世杰, 陈红英. 表达猪圆环病毒2d型Cap蛋白的重组猪伪狂犬病病毒的构建[J]. 中国畜牧兽医, 2025, 52(5): 2278-2286.
[2]	李海洋, 高永宇, 李翰文, 冯宏盛, 鲜钰涵, 杨思宇, 桑辰君, 曹玉蝶, 唐越, 李子彬, 高凤山. 口蹄疫病毒在宿主细胞增殖及免疫逃逸机制研究进展[J]. 中国畜牧兽医, 2025, 52(3): 1250-1262.
[3]	刘世雄, 李啸, 李薛强, 徐子萱, 李松建, 杜蕊, 薛晨, 刘大程. 复合菌培养物对蒙寒杂交肉羊生长性能、免疫功能及疫苗抗体效价的影响[J]. 中国畜牧兽医, 2025, 52(2): 718-729.
[4]	汪磊, 梁琳, 罗润琪, 梁瑞英, 胡丹丹, 司红彬, 丁家波, 邸文达, 汤新明. 鸡传染性贫血病疫苗研究进展[J]. 中国畜牧兽医, 2025, 52(1): 341-350.
[5]	邱东旭, 吕浪, 皮向成, 冯宇, 蒋卉, 陈祥, 丁家波. 羊用布鲁氏菌病疫苗研究进展[J]. 中国畜牧兽医, 2024, 51(9): 4043-4051.
[6]	姜鑫瑞, 冯贺龙, 杨宏春, 蒋立人, 汪宏才, 曾哲, 左波, 张腾飞, 罗青平, 商雨, 温国元. 竹叶黄酮对鸡胚接种新城疫疫苗免疫效果的影响[J]. 中国畜牧兽医, 2024, 51(9): 4174-4181.
[7]	刘青, 顾天越, 包利霞, 朱凡杰, 王鑫源, 刘婷婷, 朱晓琛, 鄢明华, 董志民, 王利丽, 张东超, 金天明. PEDV、TGEV与PDCoV S蛋白表位基因三联疫苗的构建及其鉴定[J]. 中国畜牧兽医, 2024, 51(8): 3495-3505.
[8]	鲜钰涵, 冯宏盛, 高永宇, 李海洋, 杨思宇, 桑辰君, 曹玉蝶, 唐越, 李子彬, 高凤山. 猪源病毒细胞毒性T淋巴细胞表位研究进展[J]. 中国畜牧兽医, 2024, 51(7): 3086-3099.
[9]	张关锋, 杨泰, 宋先凡, 徐伟伟, 阳治康, 陈清华. 枯草芽孢杆菌的生理功能及其在畜禽生产中的应用[J]. 中国畜牧兽医, 2024, 51(4): 1511-1519.
[10]	吴伟, 郝飞, 谢星, 冯志新. 雾化疫苗研究进展[J]. 中国畜牧兽医, 2024, 51(3): 1203-1213.
[11]	杨慧明, 蒲兴, 党海斌, 孙璐, 张国中. 不同鸡马立克病疫苗的免疫保护效果比较[J]. 中国畜牧兽医, 2024, 51(3): 1267-1276.
[12]	刘丁语, 何振文, 刘宝玲, 王刚, 王晓虎, 谭臣, 蔡汝健. 戊型肝炎病毒研究进展[J]. 中国畜牧兽医, 2024, 51(2): 736-747.
[13]	陈洪, 吴双, 车业贵, 邱树磊, 周子祥, 王奕, 王永娟, 袁橙. 基于减法蛋白组学和反向疫苗学方法设计禽致病性大肠杆菌O1和O78血清型多表位疫苗[J]. 中国畜牧兽医, 2024, 51(12): 5425-5438.
[14]	李紫薇, 张磊, 陈峰, 郑辉, 崔进, 曹振山, 张慧, 戈胜强, 魏荣, 刘拂晓, 南福龙, 沙洲, 尼博. mRNA疫苗递送系统研究进展[J]. 中国畜牧兽医, 2024, 51(11): 4932-4942.
[15]	张洋, 欧云文, 马春霞, 任绍科, 潘琴, 邓书明, 翟佳佳, 杨山山. 猪流行性腹泻疫苗研究进展[J]. 中国畜牧兽医, 2024, 51(11): 5004-5013.